Clinical Trials Browser

Phase 2 × Interventional × Liver Diseases × Clear all

Digestive System Neoplasms, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT05063565 2026-03-02

ROWAN

Adenocarcinoma, Carcinoma, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT04727307 2025-09-30

AB-LATE02

Phase 2 Recruiting

202 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases

NCT03519074 2024-09-19

Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction

Phase 2 Active not recruiting

48 enrolled

Liver Diseases, Neoplasms

NCT04518852 2024-06-25

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Phase 2 Completed

27 enrolled

Gastrointestinal

Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT03008512 2021-02-04

A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib

Phase 2 Terminated

5 enrolled

Gastrointestinal

Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Site

NCT02868242 2020-03-02

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Phase 2 Completed

19 enrolled 14 charts

Hepatitis C, Liver Diseases, Virus Diseases, Hepatitis C, Chronic

NCT01177007 2017-08-28

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

Phase 2 Completed

50 enrolled 10 charts

EndocrineGastrointestinalNET

Adenocarcinoma, Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Glandular and Epithelial, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Rectal Diseases, Colorectal Neoplasms, Neuroectodermal Tumors, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT00627042 2014-10-08

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

Phase 2 Completed

42 enrolled 19 charts

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms

NCT01215565 2014-03-13

Fibrolam

Phase 2 Terminated

4 enrolled

Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Fibrosis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Pathologic Processes

NCT01394497 2013-02-18

Use of N-Acetylcysteine During Liver Procurement

Phase 2 Completed

140 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Liver Failure, Liver Failure, Acute, Primary Graft Dysfunction

NCT01423708 2012-07-18

EPOCAL

Phase 2 Unknown

117 enrolled

Gastrointestinal

Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Liver Failure

NCT01556815 2012-04-25

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

Phase 2 Unknown

40 enrolled

Gastrointestinal

Adenocarcinoma, Carcinoma, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial

NCT01533324 2012-02-15

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)

Phase 2 Unknown

32 enrolled

Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Diseases

Clinical Trials

Kirros

ROWAN

AB-LATE02

Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy

Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors

Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy

Fibrolam

Use of N-Acetylcysteine During Liver Procurement

EPOCAL

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)